Published in:
01-01-2007 | INVITED COMMENTARY
Re: Postoperative Glycemic Control in Patients Undergoing Central Pancreatectomy for Mid-gland Lesions
Authors:
F. C. Brunicardi, MD, Nikiforos Ballian, MD
Published in:
World Journal of Surgery
|
Issue 1/2007
Login to get access
Excerpt
Despite the decreasing morbidity and mortality of standard pancreaticoduodenectomy and distal pancreatectomy, significant rates of exocrine and endocrine pancreatic insufficiency still occur.
1,
2 Central pancreatectomy for the treatment of middle segment pancreatic lesions has been gaining popularity in an attempt to preserve exocrine and endocrine tissue.
2,
3 Indications for this procedure include benign endocrine and exocrine neoplasms not amenable to enucleation, focal chronic pancreatitis, simple cysts, pseudocysts, and mucinous metaplasia.
3 Until recently, Roux-en-Y pancreaticojejunostomy was being used to drain secretions of the distal pancreatic remnant. However, pancreaticogastrostomy has been reported to offer significant benefits over the former procedure.
2 In the present study, the authors have focused on the effect of central pancreatectomy with pancreaticogastrostomy on endocrine pancreatic function. …
